139 related articles for article (PubMed ID: 37914151)
1. Lychnopholide loaded in surface modified polylactide nanocapsules (LYC-PLA-PEG-NC) cure mice infected by Trypanosoma cruzi strain a prototype of resistance to benznidazole and nifurtimox: First insights of its mechanism of action.
Milagre MM; Torchelsen FKVDS; Pedrosa TCF; Teixeira GM; Sampaio LS; Saúde-Guimarães DA; Branquinho RT; Mosqueira VCF; Lana M
Exp Parasitol; 2023 Dec; 255():108647. PubMed ID: 37914151
[TBL] [Abstract][Full Text] [Related]
2. Lychnopholide in Poly(d,l-Lactide)-
Branquinho RT; de Mello CGC; Oliveira MT; Reis LES; Vieira PMA; Saúde-Guimarães DA; Mosqueira VCF; de Lana M
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988096
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Lychnopholide Polymeric Nanocapsules after Oral and Intravenous Administration in Murine Experimental Chagas Disease.
de Mello CG; Branquinho RT; Oliveira MT; Milagre MM; Saúde-Guimarães DA; Mosqueira VC; Lana Md
Antimicrob Agents Chemother; 2016 Sep; 60(9):5215-22. PubMed ID: 27324760
[TBL] [Abstract][Full Text] [Related]
4. Sesquiterpene lactone in nanostructured parenteral dosage form is efficacious in experimental Chagas disease.
Branquinho RT; Mosqueira VC; de Oliveira-Silva JC; Simões-Silva MR; Saúde-Guimarães DA; de Lana M
Antimicrob Agents Chemother; 2014; 58(4):2067-75. PubMed ID: 24449777
[TBL] [Abstract][Full Text] [Related]
5. Trypanosoma cruzi: Does the intake of nanoencapsulated benznidazole control acute infections?
Dutra da Silva A; Fracasso M; Bottari NB; Gundel S; Ourique AF; Assmann CE; Ferreira DASP; Castro MFV; Reichert KP; de Souza LAF; da Veiga ML; da Rocha MIUM; Monteiro SG; Morsch VM; Chitolina Schetinger MR; da Silva AS
Exp Parasitol; 2023 Jun; 249():108520. PubMed ID: 37001581
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
[TBL] [Abstract][Full Text] [Related]
7. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
[TBL] [Abstract][Full Text] [Related]
8. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846
[TBL] [Abstract][Full Text] [Related]
9. Effect of B-NIPOx in Experimental
Reséndiz-Mora A; Barrera-Aveleida G; Sotelo-Rodríguez A; Galarce-Sosa I; Nevárez-Lechuga I; Santiago-Hernández JC; Nogueda-Torres B; Meza-Toledo S; Gómez-Manzo S; Wong-Baeza I; Baeza I; Wong-Baeza C
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613783
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease.
Filardi LS; Brener Z
Trans R Soc Trop Med Hyg; 1987; 81(5):755-9. PubMed ID: 3130683
[TBL] [Abstract][Full Text] [Related]
11. Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II).
Campos RF; Guerreiro ML; Sobral Kde S; Lima Rde C; Andrade SG
Rev Soc Bras Med Trop; 2005; 38(2):142-6. PubMed ID: 15821788
[TBL] [Abstract][Full Text] [Related]
12. Time and dose-dependence evaluation of nitroheterocyclic drugs for improving efficacy following Trypanosoma cruzi infection: A pre-clinical study.
Mazzeti AL; Diniz LF; Gonçalves KR; Nascimento AFS; Spósito PAF; Mosqueira VCF; Machado-Coelho GLL; Ribeiro I; Bahia MT
Biochem Pharmacol; 2018 Feb; 148():213-221. PubMed ID: 29309767
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of the chronic phase of the experimental infection by Trypanosoma cruzi with benzonidazole and nifurtimox].
Andrade SG; Magalhães JB; Pontes AL
Rev Soc Bras Med Trop; 1989; 22(3):113-8. PubMed ID: 2518608
[TBL] [Abstract][Full Text] [Related]
14. Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.
Villar JC; Herrera VM; Pérez Carreño JG; Váquiro Herrera E; Castellanos Domínguez YZ; Vásquez SM; Cucunubá ZM; Prado NG; Hernández Y
Trials; 2019 Jul; 20(1):431. PubMed ID: 31307503
[TBL] [Abstract][Full Text] [Related]
15. Reversibility of muscle and heart lesions in chronic, Trypanosoma cruzi infected mice after late trypanomicidal treatment.
Segura MA; Molina de Raspi E; Basombrio MA
Mem Inst Oswaldo Cruz; 1994; 89(2):213-6. PubMed ID: 7885247
[TBL] [Abstract][Full Text] [Related]
16. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole.
Murta SM; Romanha AJ
Parasitology; 1998 Feb; 116 ( Pt 2)():165-71. PubMed ID: 9509026
[TBL] [Abstract][Full Text] [Related]
17. In vitro interaction of polyethylene glycol-block-poly(D,L-lactide) nanocapsule devices with host cardiomyoblasts and Trypanosoma cruzi-infective forms.
Siqueira RP; Milagre MM; de Oliveira MA; Branquinho RT; Torchelsen FKV; de Lana M; Machado MGC; Andrade MS; Bahia MT; Mosqueira VCF
Parasitol Res; 2022 Oct; 121(10):2861-2874. PubMed ID: 35972545
[TBL] [Abstract][Full Text] [Related]
18. Fexinidazole: a potential new drug candidate for Chagas disease.
Bahia MT; de Andrade IM; Martins TA; do Nascimento ÁF; Diniz Lde F; Caldas IS; Talvani A; Trunz BB; Torreele E; Ribeiro I
PLoS Negl Trop Dis; 2012; 6(11):e1870. PubMed ID: 23133682
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of new 1,2,3-triazoles derived from eugenol and analogues with in vitro and in vivo activity against Trypanosoma cruzi.
Reis RCFM; Dos Santos EG; Benedetti MD; Reis ACC; Brandão GC; Silva GND; Diniz LA; Ferreira RS; Caldas IS; Braga SFP; Souza TB
Eur J Med Chem; 2023 Oct; 258():115622. PubMed ID: 37441850
[TBL] [Abstract][Full Text] [Related]
20. [Isoenzymatic pattern of Trypanosoma cruzi Y strain after specific chemotherapy].
Silva RC; Santiago CM; Pontes AL; Andrade SG
Mem Inst Oswaldo Cruz; 1989; 84(1):81-6. PubMed ID: 2108307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
